Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||043B21A / 2||LA / IM|
Administered by: Work Purchased by: ??
Symptoms: No adverse event, Product administered to patient of inappropriate age
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: Unknown
Current Illness: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: 17 year old patient received 1st dose of the Moderna vaccine at a previous clinic on 5/7/2021 despite the vaccine only being approved for use in patients 18 years and older. Based on CDC guidance and information from the manufacturer it was recommended to vaccinate patient with a second dose of the Moderna vaccine and follow the vaccine dosing schedule. No adverse effects were reported from the patient.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166